Bactroban Nasal
Bactroban Nasal is a medicine authorised by Swissmedic under authorisation number 52361. The authorisation holder is GlaxoSmithKline AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 28 January 1994 and the authorisation is valid without a time limit. ATC code R01AX06 places the medicine in the group Nasal preparations.
| Authorisation number | 52361 |
|---|---|
| Name | Bactroban Nasal |
| Full name | Bactroban Nasal, Nasensalbe |
| Authorisation holder | GlaxoSmithKline AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | R01AX06 |
| First authorisation | 28 January 1994 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Bactroban Nasal, Nasensalbe | A | 28 January 1994 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 28 | 3 | g | R01AX06 | 12.02.51 | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Bactroban Nasal authorised in Switzerland?
Yes. Bactroban Nasal is authorised by Swissmedic under authorisation number 52361, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Bactroban Nasal have?
Bactroban Nasal is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Bactroban Nasal?
The authorisation holder is GlaxoSmithKline AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.